Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Japanese soy sauce stopped at border
11/04/2025 02:50 PM - Business
Taiwan shares close down 0.77%
11/04/2025 01:50 PM - Society
Government to decide Wednesday whether to lift pig restrictions
11/04/2025 12:40 PM - Cross-Strait
50 lose Taiwanese citizenship due to Chinese identity documents
11/04/2025 12:29 PM - Society
Law enforcement authorities to launch largest ever gold auction
11/04/2025 12:20 PM